The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClontarf Regulatory News (CLON)

Share Price Information for Clontarf (CLON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0375
Bid: 0.035
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.005 (14.286%)
Open: 0.0375
High: 0.0375
Low: 0.0375
Prev. Close: 0.0375
CLON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

14 Jan 2014 15:14

RNS Number : 6428X
Clontarf Energy PLC
14 January 2014
 



14 January 2014

 

Clontarf Energy plc

("Clontarf" or "the Company")

 

Issue of Equity

 

Clontarf Energy, the AIM listed Oil Explorer, announces announces that it has today issued 7,231,975 new ordinary shares of 0.25 pence each ("Ordinary Shares") in settlement of professional fees.

 

The 7,231,975 Ordinary Shares being issued will rank pari passu in all respects with the Company's existing ordinary shares and will represent 3.5% of the Company's enlarged issued share capital. Application has been made for the 7,231,975 Ordinary Shares to be admitted to trading on AIM ("Admission") and Admission is expected to occur, and dealings are expected to commence at 8.00 am on 20 January 2014.

 

Following Admission, the Company's issued share capital will consist of 207,416,444 Ordinary Shares, with each ordinary share carrying the right to one vote. The Company does not hold any ordinary shares in treasury. This figure of 207,416,444 may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

For further information please visit http://clontarfenergy.com or contact:

 

Clontarf Energy plc

John Teeling, Chairman +353 (0) 1 833 2833

David Horgan, Managing Director

James Finn, Finance Director

 

Nominated Adviser and Joint Broker

Shore Capital

Pascal Keane/Toby Gibbs, Corporate Finance +44 (0)20 7408 4090

Jerry Keen, Corporate Broking

 

Joint Broker

Optiva Securities Limited

Jeremy King +44(0)20 3137 1904

 

Public Relations

Blythe Weigh Communications +44 (0)20 7138 3204

Tim Blythe +44 (0) 7816 924626

Eleanor Parry +44 (0) 7551 29 3620

Halimah Hussain +44 (0) 7725 978 141

 

Pembroke Communications

David O'Síocháin +353 (0) 1 649 6486

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFLELVISLIS
Date   Source Headline
10th Apr 20241:35 pmRNSGrant of Share Options
18th Mar 20247:00 amRNSBolivia Update, Fundraising and TVR
6th Mar 202410:33 amRNSEncouraging Bolivian Brines Progress
5th Feb 20247:00 amRNSSouth American Brines Progress
25th Sep 20237:00 amRNSInterim Results for the period ended 30 June 2023
1st Aug 202310:38 amRNSGrant of Share Options
13th Jul 202312:35 pmRNSResult of AGM and Corporate Update
22nd Jun 202312:32 pmRNSPosting of Annual Report and Notice of AGM
8th Jun 20237:00 amRNSPreliminary Results
1st Jun 20237:00 amRNS£350,000 Fundraising and Corporate Update
5th May 20237:00 amRNSUpdate on Joint Venture Agreement and TVR
28th Mar 202310:24 amRNSJV Agreement on Direct Lithium Extraction Bolivia
17th Feb 202311:05 amRNSSecond Price Monitoring Extn
17th Feb 202311:00 amRNSPrice Monitoring Extension
15th Feb 20237:00 amRNSJV HoA on Direct Lithium Ion Extraction in Bolivia
17th Jan 202310:34 amRNSGrant of Share Options
16th Jan 20237:00 amRNS£1.3 million Fundraising and Corporate Update
8th Nov 20224:40 pmRNSSecond Price Monitoring Extn
8th Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results for the period ended 30 June 2022
5th Sep 20227:02 amRNSShare Price Movement and Shareholder Update
4th Aug 20221:00 pmRNSResult of AGM and Capital Reorganisation
1st Jul 202211:04 amRNSDirector Change
29th Jun 202210:30 amRNSPosting of Annual Report
22nd Jun 20227:00 amRNSPreliminary Results for the Year Ended 31 Dec 2021
14th Jun 20227:00 amRNSSasanof-1 well completion
6th Jun 20227:00 amRNSSasanof-1 well final result
6th Jun 20227:00 amRNSResult of General Meeting
30th May 20228:00 amRNSSasanof-1 well drilling update
27th May 20227:00 amRNSSasanof-1 well spudding
23rd May 20227:00 amRNSSasanof-1 well mobilisation update
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
18th May 20222:06 pmRNSSecond Price Monitoring Extn
18th May 20222:00 pmRNSPrice Monitoring Extension
18th May 20227:00 amRNSSasanof-1 well mobilisation update
17th May 202211:00 amRNSPrice Monitoring Extension
12th May 202211:53 amRNSUpdate on Sasanof-1 well
11th May 20223:58 pmRNSNotice of General Meeting
10th May 20227:00 amRNSConsideration Shares to be Admitted to Trading
9th May 20227:00 amRNSAcquisition of 10% of Sasanof Prospect
27th Apr 20221:02 pmRNSPlacing to raise £3,500,000
12th Jan 20224:40 pmRNSIssue of Warrants and RPT
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
15th Sep 20217:00 amRNSInterim Statement
23rd Jun 202111:35 amRNSResult of Annual General Meeting and Board Changes
7th Jun 202110:50 amRNSPosting of Annual Report and Notice of AGM
24th May 20214:11 pmRNSTR-1: Notification of major holdings
20th May 20213:58 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.